October 1, 2021
ECRI partners with FDA on safety of materials in medical devices
Editor's Note
ECRI, on September 30, announced a new partnership with the Food and Drug Administration (FDA) to improve the safety of medical devices through the use of safer materials.
ECRI is developing safety reports for materials commonly used in implantable medical devices and assessing their possible effects on patients over time.
The first four reports are available now on FDA.gov: magnesium, polypropylene, polyurethanes, and siloxanes.
Free Daily News
- Simulation-based robotic surgery training boosts team confidence, communication
- Perioperative leaders gather at 2025 OR Manager Conference
- CMS launches 6-year model to curb wasteful Medicare spending with AI-driven reviews
- Report: Hospitals can cut anesthesia costs, burnout through tech-driven partnerships
- Study: One in four US healthcare workers faces food insecurity
- Digital decision aid boosts shared decision-making in knee replacement consultations
- CMS narrows surveys to immediate jeopardy, harm during shutdown
- Ambient AI turns burnout relief into 'hard ROI' at Seattle Children’s
- Robotics redefine cardiac surgery with precision, smaller incisions, new frontiers in AI and telesurgery
- Private equity bets big on outpatient cardiology as CMS boosts reimbursements
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement